CXCR2(+) MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion.
CXCR2(+) MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion.
复制标题
CXCR2( ) MDSC 通过诱导 EMT 和活化 T 细胞耗竭促进乳腺癌进展
DOI:
10.18632/oncotarget.23020
复制
发表时间:
2017-12-29
期刊:
影响因子:
--
通讯作者:
Liu Q
中科院分区:
文献类型:
--
作者:
Zhu H;Gu Y;Xue Y;Yuan M;Cao X;Liu Q
Although myeloid-derived suppressor cells (MDSCs) have been demonstrated to contribute to tumor initiation, progression and metastasis, however, which MDSC subsets are preferentially expanded and activated, and what’s the key molecular mechanism responsible for specific MDSC subsets in promoting tumor progression need to be fully addressed. Here we identify that Ly6GmiLy6CloCD11b+CXCR2+ subpopulation (named CXCR2+ MDSCs) are predominately expanded and recruited in systemic and local tumor microenvironment during breast cancer progression and metastasis. The proportion of CXCR2+ MDSCs is inversely correlated with the infiltration of CD4+ or CD8+ T cells. Besides, CXCR2+ MDSCs promote breast cancer growth and metastasis to lung and/or lymph node in vivo. Furthermore, CXCR2+ MDSCs induce epithelial mesenchymal transition (EMT) of breast cancer cells via IL-6. Moreover, CXCR2+ MDSCs upregulate the expression of immunosuppressive molecules programmed cell death protein 1(PD1), PD1 ligand 1 (PDL1), lymphocyte activation gene 3 protein (LAG3), cytotoxic T lymphocyte antigen 4 (CTLA4), and T cell immunoglobulin domain and mucin domain protein 3 (TIM3) on CD4+ or CD8+ T cells, and induce exhaustion of the activated T cells partially via IFN-γ. These results demonstrate that CXCR2+ MDSCs accelerate breast cancer progression via directly inducing cancer cell EMT and indirectly promoting T cell exhaustion, suggesting that CXCR2+ MDSCs may be a potential therapeutic target of breast cancer.
登录
查看更多内容
影响因子:
3.7
作者:
Mucha J;Majchrzak K;Taciak B;Hellmén E;Król M
通讯作者:
Król M
影响因子:
11.2
作者:
Peng D;Tanikawa T;Li W;Zhao L;Vatan L;Szeliga W;Wan S;Wei S;Wang Y;Liu Y;Staroslawska E;Szubstarski F;Rolinski J;Grywalska E;Stanisławek A;Polkowski W;Kurylcio A;Kleer C;Chang AE;Wicha M;Sabel M;Zou W;Kryczek I
通讯作者:
Kryczek I
影响因子:
3.9
作者:
Felipe Lima J;Nofech-Mozes S;Bayani J;Bartlett JM
通讯作者:
Bartlett JM
影响因子:
17.1
作者:
Highfill SL;Cui Y;Giles AJ;Smith JP;Zhang H;Morse E;Kaplan RN;Mackall CL
通讯作者:
Mackall CL
影响因子:
64.5
作者:
Acharyya S;Oskarsson T;Vanharanta S;Malladi S;Kim J;Morris PG;Manova-Todorova K;Leversha M;Hogg N;Seshan VE;Norton L;Brogi E;Massagué J
通讯作者:
Massagué J